Chemistry Review of Vaping Products and Respiratory Injury
Background: While the Public Health Agency of Canada notes 19 cases from May 2019 to February 2020 relating to e-cigarette or vaping product use-associated lung injury (EVALI) in Canada, there are likely many more unreported cases, including non-hospitalized and asymptomatic cases. E-cigarette use o...
Main Authors: | Chester Lau, Ran Zhao, Dilini Vethanayagam |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Alberta Library
2020-11-01
|
Series: | Spectrum |
Online Access: | https://spectrumjournal.ca/index.php/spectrum/article/view/92 |
Similar Items
-
Vaping in today’s pandemic: E-cigarette, or vaping, product use–associated lung injury mimicking COVID-19 in teenagers presenting with respiratory distress
by: Daphne O Darmawan, et al.
Published: (2020-10-01) -
E-cigarette, or vaping, product use-associated lung injury: a review
by: Samuel H. Belok, et al.
Published: (2020-10-01) -
Impact of vaping and smoking on maximum respiratory pressures and respiratory function
by: Mohammad Z. Darabseh, et al.
Published: (2021-01-01) -
Review of Cases of E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Brief Review of the Literature
by: Amr Essa, et al.
Published: (2020-01-01) -
Severe respiratory disease associated with vaping: a case report
by: Schmitz ED
Published: (2019-09-01)